Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M96.7Revenue (TTM) $M459Net Margin (%)--Altman Z-Score--
Enterprise Value $M--EPS (TTM) $4.5Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %0.9PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M16.1ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with BTH

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

BTH is held by these investors:

BTH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cirillo JosephVP and CAO 2014-08-08Sell0$0view
Casey JaneVP and CFO 2014-08-08Sell0$0view
Williams James IIIDirector 2014-08-07Sell0$0view
Dietze Jane ADirector 2014-03-12Sell0$0view
Goergen Todd Andrew10% Owner 2013-09-17Buy20,000$12.34-51.46view
GOERGEN ROBERT BChairman of the Board & CEO, 10% Owner 2013-09-10Buy10,000$10.57-43.33view
GOERGEN PAMELA MDirector 2013-09-10Buy10,000$10.57-43.33view
BLAIR RYANVice President 2013-08-30Buy20,000$9.15-34.54view
Graham AndrewDirector 2013-08-08Sell0$0-34.54view
BLAIR RYANVice President 2013-06-20Buy12,148$13.85-56.75view

Press Releases about BTH :

Quarterly/Annual Reports about BTH:

    News about BTH:

    Articles On GuruFocus.com
    Breathtec Biomedical Announces Plans for Breath Analysis Clinical Trials at Canadian Tech Facility Jun 28 2016 
    Breathtec BioMedical Appoints Guy LaTorre as Chief Executive Officer Jun 20 2016 
    Breathtec Biomedical Closes License of NA-NOSE Technology for Disease Detection May 24 2016 
    Breathtec Biomedical Announces Trading on OTCQB May 19 2016 
    Breathtec Biomedical Announces Prof. Hossam Haick as Consultant Apr 19 2016 
    Breathtec Biomedical In-Licenses Advanced Stage Breath Analysis Technology Apr 13 2016 
    Breathtec Biomedical Provides Update on Lead Project and In-Licensing Discussions Apr 04 2016 
    Breathtec Biomedical Appoints Experienced Product Development and Regulatory Consultant Feb 22 2016 
    UPDATE - Breathtec Biomedical Commences Trading on the Canadian Securities Exchange (CSE: BTH) Feb 01 2016 
    Breathtec Biomedical Commences Trading on the Canadian Securities Exchange (CSE: BTH) Feb 01 2016 

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

    GF Chat